Also known as Chugai Pharma USA.
None yet. When a new project in the record names CPUSA as owner, partner or investor, it shows here.
Multi-year framework to streamline early-stage target discovery and therapeutic development using antibody engineering, macrocyclic peptides and small-molecule platforms.
